Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)
Go back to Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)| (NASDAQ: LNTH) | Delayed: 100.55 -0.25 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.80 | 52 Week High | $10.70 | |||
| Open | $100.79 | 52 Week Low | $1.76 | |||
| Day High | $100.96 | P/E | N/A | |||
| Day Low | $100.48 | EPS | $0.00 | |||
| Volume | 1,027,913 | |||||
